IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 42 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $45,150 | -5.9% | 129,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $48,000 | -18.6% | 129,000 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $59,000 | -10.6% | 129,000 | -1.5% | 0.01% | +16.7% |
| Q1 2022 | $66,000 | -21.4% | 131,000 | -10.3% | 0.01% | -14.3% |
| Q4 2021 | $84,000 | -42.1% | 146,000 | +3.5% | 0.01% | -46.2% |
| Q3 2021 | $145,000 | -14.2% | 141,000 | 0.0% | 0.01% | -13.3% |
| Q2 2021 | $169,000 | -7.7% | 141,000 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $183,000 | -44.7% | 141,000 | +56.7% | 0.02% | -51.4% |
| Q4 2020 | $331,000 | +72.4% | 90,000 | 0.0% | 0.04% | +52.2% |
| Q3 2020 | $192,000 | +392.3% | 90,000 | +317.2% | 0.02% | +360.0% |
| Q2 2020 | $39,000 | +39.3% | 21,571 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $28,000 | -28.2% | 21,571 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $39,000 | -66.7% | 21,571 | -46.5% | 0.00% | -71.4% |
| Q3 2019 | $117,000 | +8.3% | 40,321 | 0.0% | 0.01% | +7.7% |
| Q2 2019 | $108,000 | +96.4% | 40,321 | +86.9% | 0.01% | +85.7% |
| Q1 2019 | $55,000 | 0.0% | 21,571 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $55,000 | 0.0% | 21,571 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $55,000 | – | 21,571 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |